Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2018

01-02-2018 | Research Article

The quality of information on the internet relating to top-selling dietary supplements in the Czech Republic

Authors: L. Baudischova, J. Straznicka, J. Pokladnikova, L. Jahodar

Published in: International Journal of Clinical Pharmacy | Issue 1/2018

Login to get access

Abstract

Background The purchase of dietary supplements (DS) via the Internet is increasing worldwide as well as in the Czech Republic. Objective The aim of the study is to evaluate the quality of information on DS available on the Internet. Setting Czech websites related to dietary supplements. Methods A cross-sectional study was carried out involving the analysis of information placed on the websites related to the 100 top-selling DS in the Czech Republic in 2014, according to IMS Health data. Main outcome measure The following criteria were evaluated: contact for the manufacturer, recommended dosage, information on active substances as well as overall composition, permitted health claims, % of the daily reference intake value (DRIV) for vitamins and minerals, link for online counseling, pregnancy/breastfeeding, allergy information, contraindications, adverse reactions, and supplement-drug interactions (some criteria were evaluated from both points of view). Results A total of 199 web domains and 850 websites were evaluated. From the regulatory point of view, all the criteria were fulfilled by 11.3% of websites. Almost 9% of the websites reported information referring to the treatment, cure, or prevention of a disease. From the clinical point of view, all the criteria were only met by one website. Conclusions The quality of information related to DS available on the Internet in the Czech Republic is quite low. The consumers should consult a specialist when using DS purchased online.
Literature
3.
go back to reference Harrison RA, Holt D, Pattison DJ, Elton PJ. Are those in need taking dietary supplements? A survey of 21 923 adults. Br J Nutr. 2004;91:617–23.CrossRefPubMed Harrison RA, Holt D, Pattison DJ, Elton PJ. Are those in need taking dietary supplements? A survey of 21 923 adults. Br J Nutr. 2004;91:617–23.CrossRefPubMed
4.
go back to reference Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, et al. Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study. Eur J Clin Nutr. 2009;63:273–81.CrossRefPubMed Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, et al. Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study. Eur J Clin Nutr. 2009;63:273–81.CrossRefPubMed
5.
go back to reference Beitz R, Mensink GBM, Rams S, Döring A. Vitamin-und Mineralstoffsupplementierung in Deutschland. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz. 2004;47:1057–65.PubMed Beitz R, Mensink GBM, Rams S, Döring A. Vitamin-und Mineralstoffsupplementierung in Deutschland. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz. 2004;47:1057–65.PubMed
7.
go back to reference Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23:22–8.PubMed Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23:22–8.PubMed
16.
go back to reference Owens CH, Baergen R, Puckett D. Online sources of herbal product information. Am J Med. 2014;127:109–15.CrossRefPubMed Owens CH, Baergen R, Puckett D. Online sources of herbal product information. Am J Med. 2014;127:109–15.CrossRefPubMed
17.
go back to reference Conesa-Fuentes MC, Hernandez-Morante JJ. Prospective analysis of the quality of Spanish health information web sites after 3 years. Inf Health Soc Care. 2016;41:417–29.CrossRef Conesa-Fuentes MC, Hernandez-Morante JJ. Prospective analysis of the quality of Spanish health information web sites after 3 years. Inf Health Soc Care. 2016;41:417–29.CrossRef
21.
go back to reference Morrow JD, Edeki TI, El Mouelhi M, Galinsky RE, Kovelesky R, Noveck RJ, et al. American society for clinical pharmacology and therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther. 2005;77:113–22.CrossRefPubMed Morrow JD, Edeki TI, El Mouelhi M, Galinsky RE, Kovelesky R, Noveck RJ, et al. American society for clinical pharmacology and therapeutics position statement on dietary supplement safety and regulation. Clin Pharmacol Ther. 2005;77:113–22.CrossRefPubMed
22.
go back to reference Ashar BH, Miller RG, Getz KJ, Pichard CP. A critical evaluation of internet marketing of products that contain ephedra. Mayo Clin Proc. 2003;78:944–6.CrossRefPubMed Ashar BH, Miller RG, Getz KJ, Pichard CP. A critical evaluation of internet marketing of products that contain ephedra. Mayo Clin Proc. 2003;78:944–6.CrossRefPubMed
23.
go back to reference Kohout P. Celiac disease diagnosis and treatment. Interní Med. 2006;7–8:324–6. Kohout P. Celiac disease diagnosis and treatment. Interní Med. 2006;7–8:324–6.
26.
go back to reference Roe B, Levy AS, Derby BM. The impact of health claims on consumer search and product evaluation outcomes: results from FDA experimental data. J Public Policy Mark. 1999;18:89–105. Roe B, Levy AS, Derby BM. The impact of health claims on consumer search and product evaluation outcomes: results from FDA experimental data. J Public Policy Mark. 1999;18:89–105.
27.
go back to reference Crocco AG. Analysis of cases of harm associated with use of health information on the internet. JAMA. 2002;287:2869–71.CrossRefPubMed Crocco AG. Analysis of cases of harm associated with use of health information on the internet. JAMA. 2002;287:2869–71.CrossRefPubMed
28.
go back to reference Jordan MA, Haywood T. Evaluation of internet websites marketing herbal weight-loss supplements to consumers. J Altern Complement Med. 2007;13:1035–43.CrossRefPubMed Jordan MA, Haywood T. Evaluation of internet websites marketing herbal weight-loss supplements to consumers. J Altern Complement Med. 2007;13:1035–43.CrossRefPubMed
29.
go back to reference Kaplan YC, Demir Ö, Karadaş B, Kaplan MD. Online weight loss supplement market and public health: an analysis of Turkish websites marketing weight loss supplements. CMJ. 2012;34:138–45.CrossRef Kaplan YC, Demir Ö, Karadaş B, Kaplan MD. Online weight loss supplement market and public health: an analysis of Turkish websites marketing weight loss supplements. CMJ. 2012;34:138–45.CrossRef
30.
go back to reference Nazeri A, Massumi A, Wilson JM, Frank CM, Bensler M, Cheng J, et al. Arrhythmogenicity of weight-loss supplements marketed on the internet. Heart Rhythm. 2009;6:658–62.CrossRefPubMed Nazeri A, Massumi A, Wilson JM, Frank CM, Bensler M, Cheng J, et al. Arrhythmogenicity of weight-loss supplements marketed on the internet. Heart Rhythm. 2009;6:658–62.CrossRefPubMed
31.
go back to reference Stevens LJ, Kuczek T, Burgess JR, Stochelski MA, Arnold LE, Galland L. Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children. Nutr Rev. 2013;71:268–81.CrossRefPubMed Stevens LJ, Kuczek T, Burgess JR, Stochelski MA, Arnold LE, Galland L. Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children. Nutr Rev. 2013;71:268–81.CrossRefPubMed
32.
go back to reference Stevens LJ, Burgess JR, Stochelski MA, Kuczek T. Amounts of artificial food colors in commonly consumed beverages and potential behavioral implications for consumption in children. Clin Pediatr. 2014;53:133–40.CrossRef Stevens LJ, Burgess JR, Stochelski MA, Kuczek T. Amounts of artificial food colors in commonly consumed beverages and potential behavioral implications for consumption in children. Clin Pediatr. 2014;53:133–40.CrossRef
33.
go back to reference Udo IA, Festus A. Concomitant use of dietary supplements and orthodox medicines among primary care patients’ due to non-communication with physicians in a tertiary hospital in Uyo. MRJMMS. 2016;4:266–71. Udo IA, Festus A. Concomitant use of dietary supplements and orthodox medicines among primary care patients’ due to non-communication with physicians in a tertiary hospital in Uyo. MRJMMS. 2016;4:266–71.
34.
go back to reference Moses GM, Mcguire TM. Drug interactions with complementary medicines. Aust Prescr. 2010;33:177–80.CrossRef Moses GM, Mcguire TM. Drug interactions with complementary medicines. Aust Prescr. 2010;33:177–80.CrossRef
35.
go back to reference Vamenta-Morris H, Dreisbach A, Shoemaker-Moyle M, Abdel-Rahman EM. Internet claims on dietary and herbal supplements in advanced nephropathy: truth or myth. Am J Nephrol. 2014;40:393–8.CrossRefPubMed Vamenta-Morris H, Dreisbach A, Shoemaker-Moyle M, Abdel-Rahman EM. Internet claims on dietary and herbal supplements in advanced nephropathy: truth or myth. Am J Nephrol. 2014;40:393–8.CrossRefPubMed
37.
go back to reference Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a veterans administration hospital. Am J Clin Oncol. 2006;29:178–82.CrossRefPubMed Lee AH, Ingraham SE, Kopp M, Foraida MI, Jazieh AR. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a veterans administration hospital. Am J Clin Oncol. 2006;29:178–82.CrossRefPubMed
38.
go back to reference Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med. 2004;164:630–6.CrossRefPubMed Peng CC, Glassman PA, Trilli LE, Hayes-Hunter J, Good CB. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med. 2004;164:630–6.CrossRefPubMed
39.
go back to reference Agency for Healthcare Research and Quality (US). Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care. In: Advances in patient safety: new directions and alternative approaches (Vol. 4: Technology and Medication Safety). Rockville (MD); 2008. Agency for Healthcare Research and Quality (US). Risk of concurrent use of prescription drugs with herbal and dietary supplements in ambulatory care. In: Advances in patient safety: new directions and alternative approaches (Vol. 4: Technology and Medication Safety). Rockville (MD); 2008.
41.
go back to reference Sayakhot P, Carolan-Olah M. Internet use by pregnant women seeking pregnancy-related information: a systematic review. BMC Pregnancy Childbirth. 2016;16:65.CrossRefPubMedPubMedCentral Sayakhot P, Carolan-Olah M. Internet use by pregnant women seeking pregnancy-related information: a systematic review. BMC Pregnancy Childbirth. 2016;16:65.CrossRefPubMedPubMedCentral
Metadata
Title
The quality of information on the internet relating to top-selling dietary supplements in the Czech Republic
Authors
L. Baudischova
J. Straznicka
J. Pokladnikova
L. Jahodar
Publication date
01-02-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0564-x

Other articles of this Issue 1/2018

International Journal of Clinical Pharmacy 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.